Taylor M Triolo

Summary

Affiliation: University of Colorado Denver
Country: USA

Publications

  1. pmc Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset
    Taylor M Triolo
    University of Colorado Denver, Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, USA
    Diabetes Care 32:769-73. 2009
  2. pmc Additional autoimmune disease found in 33% of patients at type 1 diabetes onset
    Taylor M Triolo
    Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, USA
    Diabetes Care 34:1211-3. 2011
  3. pmc Dominant suppression of Addison's disease associated with HLA-B15
    Peter R Baker
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado 80045 6511, USA
    J Clin Endocrinol Metab 96:2154-62. 2011
  4. pmc Haplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's disease
    Peter R Baker
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado 80045 6511, USA
    J Clin Endocrinol Metab 95:E263-70. 2010
  5. pmc Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes
    Taylor M Triolo
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Health Science Center, Aurora, CO 80045, USA
    J Clin Endocrinol Metab 94:4517-23. 2009
  6. pmc Two single nucleotide polymorphisms identify the highest-risk diabetes HLA genotype: potential for rapid screening
    Jennifer M Barker
    Barbara Davis Center for Childhood Diabetes, University of Coloradoat Denver, Colorado, USA
    Diabetes 57:3152-5. 2008
  7. doi request reprint Etiology of insulin resistance in youth with type 2 diabetes
    Melanie Cree-Green
    Division of Endocrinology, Department of Pediatrics, University of Colorado Denver and the Children s Hospital Colorado, Box 265, 13123 E Colfax Avenue, Aurora, CO 80045, USA
    Curr Diab Rep 13:81-8. 2013

Detail Information

Publications7

  1. pmc Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset
    Taylor M Triolo
    University of Colorado Denver, Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, USA
    Diabetes Care 32:769-73. 2009
    ..Metabolic tests and the presence of symptoms were described at diabetes onset during the Diabetes Prevention Trial-Type 1 (DPT-1)...
  2. pmc Additional autoimmune disease found in 33% of patients at type 1 diabetes onset
    Taylor M Triolo
    Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, USA
    Diabetes Care 34:1211-3. 2011
    ..We sought to define the prevalence of nonislet, organ-specific autoantibodies at diagnosis of type 1 diabetes and to determine the prevalence of comorbid autoimmune diseases...
  3. pmc Dominant suppression of Addison's disease associated with HLA-B15
    Peter R Baker
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado 80045 6511, USA
    J Clin Endocrinol Metab 96:2154-62. 2011
    ..Highest genetic risk is associated with the Major Histocompatibility region (MHC), specifically human leukocyte antigen (HLA)-DR3 haplotypes (containing HLA-B8) and HLA-DR4...
  4. pmc Haplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's disease
    Peter R Baker
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado 80045 6511, USA
    J Clin Endocrinol Metab 95:E263-70. 2010
    ..Multiple autoimmune disorders (e.g. Addison's disease, type 1 diabetes, celiac disease) are associated with HLA-DR3, but it is likely that alleles of additional genes in linkage disequilibrium with HLA-DRB1 contribute to disease...
  5. pmc Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes
    Taylor M Triolo
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Health Science Center, Aurora, CO 80045, USA
    J Clin Endocrinol Metab 94:4517-23. 2009
    ..Subjects with type 1 diabetes (T1D) are at increased risk for AD. Genetic factors including HLA-DRB1*0404 and MICA have been associated with AD in populations with and without T1D...
  6. pmc Two single nucleotide polymorphisms identify the highest-risk diabetes HLA genotype: potential for rapid screening
    Jennifer M Barker
    Barbara Davis Center for Childhood Diabetes, University of Coloradoat Denver, Colorado, USA
    Diabetes 57:3152-5. 2008
    ..We sought to find an inexpensive, rapid test to identify DR3/4-DQ8 subjects using two single nucleotide polymorphisms (SNPs)...
  7. doi request reprint Etiology of insulin resistance in youth with type 2 diabetes
    Melanie Cree-Green
    Division of Endocrinology, Department of Pediatrics, University of Colorado Denver and the Children s Hospital Colorado, Box 265, 13123 E Colfax Avenue, Aurora, CO 80045, USA
    Curr Diab Rep 13:81-8. 2013
    ..Further understanding of IR, the progression to T2DM in youth, and later outcomes as adults will help direct future therapies and interventions for youth at risk...